Beyond Blood Cancers: CAR-T’s Expanding Frontier
Beyond Blood Cancers: CAR-T’s Expanding Frontier Read More »
Victor Moreno, MD, PhD
Wearable Technology in Early-Phase Cancer Trials: Advancing Objective Performance Measures
The integration of wearable technology into early-phase cancer trials represents a pivotal moment in oncology research, offering the ability to transform how we assess and predict clinical outcomes for patients. Traditional methods such as the Karnofsky Performance Status (developed in 1948) and ECOG Performance Status (introduced in 1982) have been the gold standard for decades.
Driving Oncology Research Progress Through Access to Early-Phase Trials
The START Center for Cancer Research represents a global team of leading investigators in medical oncology, driven by a commitment to improving clinical trial access for patients treated in community oncology centers. Emiliano Calvo, MD, PhD, and Victor Moreno, MD, PhD, serve as Directors of Clinical Research at START Madrid-CIOCC and START Madrid-FJD, respectively. As
Driving Oncology Research Progress Through Access to Early-Phase Trials Read More »
